Novel effects of the acyl-coenzyme A:cholesterol acyltransferase inhibitor 58-035 on foam cell development in primary human monocyte-derived macrophages

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 9, 1999, Pages 2199-2206

  Rodriguez, Annabelle ^a   Bachorik, Paul S ^b   Wee, Siok Bi ^a  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cholesterol efflux; Foam cells; Human macrophages; Modified lipoproteins

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; ACYL COENZYME A; ADENINE; CELL PROTEIN; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; CHOLESTEROL ESTER; CHOLESTEROL OLEATE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LACTATE DEHYDROGENASE; STEROL;

ARTICLE; ATHEROSCLEROSIS; BINDING AFFINITY; CELL CULTURE; CELL MATURATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME RELEASE; FEMALE; FOAM CELL; GLUCOSE UTILIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0032868510     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.9.2199     Document Type: Article

References (29)

1. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
2. Brown MS, Ho YK, Goldstein JL. The cholesteryl ester cycle in macrophage foam cells. J Biol Chem. 1980;255:9344-9352.
3. Xu X-X, Tabas I. Lipoproteins activate acyl-coenzyme A:cholesterol acyltransferase in macrophages only after cellular cholesterol pools are expanded to a critical threshold level. J Biol Chem. 1991;266: 17040-17048.
4. Matsuda K. ACAT inhibitors as antiatherosclerotic agents: compounds and mechanisms. Med Res Rev. 1994;14:271-305.
5. Bocan TMA, Mueller SB, Uhlendorf PD, Newton RS, Krause BR. Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. Arterioscler Thromb. 1991;11:1830-1843.
6. Murakami S, Araki H, Otomo S, Nara Y, Yamori Y. Effects of HL-004, a novel ACAT inhibitor, on cholesterol accumulation and removal in cultured smooth muscle cells from stroke-prone spontaneously hypertensive rats (SHRSP). Life Sci. 1995;56:509-520.
7. Murakami S, Nara Y, Yamori Y. Peritoneal macrophages from stroke-prone spontaneously hypertensive rats accumulate more cholesteryl ester than do macrophages from Wistar-Kyoto rats. Biochem Biophys Res Commun. 1995;211:547-553.
8. 2+ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. Arteriosclerosis. 1988;8:46-56.
9. Fogelman A, Schecter I, Seager J. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci U S A. 1980;77:2214-2218.
10. Kruth HS, Skarlatos SI, Gaynor PM, Gamble W. Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux. J Biol Chem. 1994;269:24511-24518.
11. Zhang W-Y, Gaynor PM, Kruth HS. Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors. J Biol Chem. 1996;271:28641-28645.
12. Kogushi M, Tanaka H, Kobayashi H, Yamada T, Ohtsuka I, Kimura T, Saito I. Effect of E5324, a novel inhibitor of acyl-CoA:cholesterol acyltransferase, on cholesteryl ester synthesis and accumulation in macrophages. Jpn J Pharmacol. 1995;68:191-199.
13. Havel RJ, Eder HA, Bragdon JH. Distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
14. Rodriguez A, Kafonek SD, Georgopoulos A, Bachorik PS. Cell density can affect cholesteryl ester accumulation in the human THP-1 macrophage. J Lipid Res. 1994;35:1909-1917.
15. Bamberger MJ, Glick JM, Rothblat GH. Hepatic lipase stimulates the uptake of high density lipoprotein cholesterol by hepatoma cells. J Lipid Res. 1983;24:869-876.
16. Frankel-Conrat H. Methods for investigating the essential groups for enzyme activity. Methods Enzymol. 1957;4:247-269.
17. Bernard DW, Rodriguez A, Glick JM, Rothblat GH. Influence of high density lipoprotein on esterified cholesterol stores in macrophages and hepatoma cells. Arteriosclerosis. 1990;10:135-144.
18. Brown MS, Ho YK, Goldstein JL. The cholesteryl ester cycle in macrophage foam cells. J Biol Chem. 1980;255:9344-9352.
19. Ishikawa TT, MacGee J, Morrison JA, Glueck CJ. Quantitative analysis of cholesterol in 5 to 20 microliters of plasma. J Lipid Res. 1974;15: 286-291.
20. Markwell MK, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978;87:206-210.
21. Faust JR, Goldstein JL, Brown MS. Receptor-mediated uptake of low density lipoprotein and utilization of its cholesterol for steroid synthesis in cultured mouse adrenal cells. J Biol Chem. 1977;252:4861-4871.
22. McFarlane AS, Koj A. Short-term measurement of catabolic rates using iodine-labeled plasma proteins. J Clin Invest. 1970;49:1903-1911.
23. Bachorik PS, Franklin FA, Virgil DG, Kwiterovich PO. High affinity uptake and degradation of apolipoprotein E-free high density lipoprotein in cultured porcine hepatocytes. Biochemistry. 1982;21:4675-4684.
24. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem. 1959;37:911-917.
25. Current Protocols in Molecular Biology: Analysis of Proteins. New York, NY: John Wiley & Sons; 1997:10.8.1.
26. Warner GJ, Stoudt G, Bamberger M, Johnson WJ, Rothblat GH. Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol. J Biol Chem. 1995; 270:5772-5778.
27. Hakamata H, Miyazaki A, Sakai M, Sakamoto Y, Matsuo H, Kihara K, Horiuchi S. Differential effects of an acyl-coenzyme A:cholesterol acyltransferase inhibitor on HDL-induced cholesterol efflux from rat macrophage foam cells. FEBS Lett. 1995;363:29-32.
28. White DA, Heffron F, Knight D, Salter AM. The effects of two acylcoenzyme A:cholesterol acyltransferase (ACAT) inhibitors, cyclandelate and a nonhydrolysable ether analogue, benzy13,3,5-trimethylcyclohexanol on low density lipoprotein metabolism in macrophages and hepatocytes. Biochem Pharmacol. 1994;48:915-922.
29. Scheithe R, Heidenthal AK, Danesch U, Mautner E, Hapfelmeier G, Becker A, Pietsch A, Webber PC, Hrboticky N. Acetylated LDL endocytosis by the human monocytic mono mac 6sr cells is not mediated by the macrophage types I and II scavenger receptors. Arterioscler Thromb Vasc Biol. 1997;17:1024-1031.